{"id":"https://openalex.org/W4389527245","doi":"https://doi.org/10.1200/jco.23.02214","title":"Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study","display_name":"Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study","publication_year":2023,"publication_date":"2023-12-10","ids":{"openalex":"https://openalex.org/W4389527245","doi":"https://doi.org/10.1200/jco.23.02214","pmid":"https://pubmed.ncbi.nlm.nih.gov/38072625","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11741176"},"language":"en","primary_location":{"id":"doi:10.1200/jco.23.02214","doi":"https://doi.org/10.1200/jco.23.02214","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.23.02214","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11741176/pdf/nihms-2037856.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100438316","display_name":"Michael L. Wang","orcid":"https://orcid.org/0000-0001-9748-5486","observed_orcids":["https://orcid.org/0000-0001-9748-5486"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Wang","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":"https://orcid.org/0000-0001-9748-5486","affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005565037","display_name":"Tanya Siddiqi","orcid":"https://orcid.org/0000-0001-5292-8298","observed_orcids":["https://orcid.org/0000-0001-5292-8298"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tanya Siddiqi","raw_affiliation_strings":["City of Hope National Medical Center, Duarte, CA"],"raw_orcid":"https://orcid.org/0000-0001-5292-8298","affiliations":[{"raw_affiliation_string":"City of Hope National Medical Center, Duarte, CA","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010130956","display_name":"Leo I. Gordon","orcid":"https://orcid.org/0000-0003-1666-7064","observed_orcids":["https://orcid.org/0000-0003-1666-7064"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]},{"id":"https://openalex.org/I4390039227","display_name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","ror":"https://ror.org/02p4far57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348","https://openalex.org/I4390039227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leo I. Gordon","raw_affiliation_strings":["Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL"],"raw_orcid":"https://orcid.org/0000-0003-1666-7064","affiliations":[{"raw_affiliation_string":"Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL","institution_ids":["https://openalex.org/I111979921","https://openalex.org/I4390039227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000537427","display_name":"Manali Kirtikumar Kamdar","orcid":"https://orcid.org/0000-0002-1930-152X","observed_orcids":["https://orcid.org/0000-0002-1930-152X"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manali Kamdar","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088179815","display_name":"Matthew Alexander Lunning","orcid":"https://orcid.org/0000-0002-2761-7612","observed_orcids":["https://orcid.org/0000-0002-2761-7612"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Lunning","raw_affiliation_strings":["University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043131622","display_name":"Alexandre V. Vinaud Hirayama","orcid":"https://orcid.org/0000-0001-7980-3882","observed_orcids":["https://orcid.org/0000-0001-7980-3882"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandre V. Hirayama","raw_affiliation_strings":["Fred Hutchinson Cancer Center, Seattle, WA"],"raw_orcid":"https://orcid.org/0000-0001-7980-3882","affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002103749","display_name":"Jeremy S. Abramson","orcid":"https://orcid.org/0000-0001-8467-9257","observed_orcids":["https://orcid.org/0000-0001-8467-9257"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy S. Abramson","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0001-8467-9257","affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016770040","display_name":"Jon E. Arnason","orcid":"https://orcid.org/0000-0001-9038-7277","observed_orcids":["https://orcid.org/0000-0001-9038-7277"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jon Arnason","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074766331","display_name":"Nilanjan Ghosh","orcid":"https://orcid.org/0000-0002-3848-6136","observed_orcids":["https://orcid.org/0000-0002-3848-6136","https://orcid.org/0000-0002-7217-243X"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nilanjan Ghosh","raw_affiliation_strings":["Atrium Health, Levine Cancer Institute, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atrium Health, Levine Cancer Institute, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030631799","display_name":"Amitkumar Mehta","orcid":"https://orcid.org/0000-0003-0537-4207","observed_orcids":["https://orcid.org/0000-0003-0537-4207"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amitkumar Mehta","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068715900","display_name":"Charalambos Babis Andreadis","orcid":"https://orcid.org/0000-0003-4681-6227","observed_orcids":["https://orcid.org/0000-0003-4681-6227"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charalambos Andreadis","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006999192","display_name":"Scott R. Solomon","orcid":"https://orcid.org/0000-0003-2061-8126","observed_orcids":["https://orcid.org/0000-0003-2061-8126"]},"institutions":[{"id":"https://openalex.org/I101890099","display_name":"Northside Hospital","ror":"https://ror.org/01g63ab19","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I101890099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott R. Solomon","raw_affiliation_strings":["Northside Hospital Cancer Institute, Atlanta, GA"],"raw_orcid":"https://orcid.org/0000-0003-2061-8126","affiliations":[{"raw_affiliation_string":"Northside Hospital Cancer Institute, Atlanta, GA","institution_ids":["https://openalex.org/I101890099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112535070","display_name":"Ana Kosti\u0107","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ana Kostic","raw_affiliation_strings":["Bristol Myers Squibb, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Seattle, WA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108654277","display_name":"Christine Dehner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Dehner","raw_affiliation_strings":["Bristol Myers Squibb, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Seattle, WA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029530100","display_name":"Ricardo Espinola","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ricardo Espinola","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108117554","display_name":"Lily H. Peng","orcid":"https://orcid.org/0009-0007-5552-5428","observed_orcids":["https://orcid.org/0009-0007-5552-5428"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lily Peng","raw_affiliation_strings":["Bristol Myers Squibb, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Seattle, WA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059141673","display_name":"Ken Ogasawara","orcid":"https://orcid.org/0000-0002-4264-8927","observed_orcids":["https://orcid.org/0000-0002-4264-8927"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ken Ogasawara","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":"https://orcid.org/0000-0002-4264-8927","affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075505073","display_name":"Amy M. Chattin","orcid":"https://orcid.org/0009-0000-1099-1678","observed_orcids":["https://orcid.org/0009-0000-1099-1678"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Chattin","raw_affiliation_strings":["Bristol Myers Squibb, Seattle, WA"],"raw_orcid":"https://orcid.org/0009-0000-1099-1678","affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Seattle, WA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082971929","display_name":"Laurie Eliason","orcid":"https://orcid.org/0009-0002-7778-9890","observed_orcids":["https://orcid.org/0009-0002-7778-9890","https://orcid.org/0000-0001-9813-6800"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laurie Eliason","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052659722","display_name":"Maria Lia Palomba","orcid":"https://orcid.org/0000-0001-5099-9156","observed_orcids":["https://orcid.org/0000-0001-5099-9156"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Lia Palomba","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":"https://orcid.org/0000-0001-5099-9156","affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":16,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":13.9572,"has_fulltext":true,"cited_by_count":119,"citation_normalized_percentile":{"value":0.99384007,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"42","issue":"10","first_page":"1146","last_page":"1157"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0340999998152256,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lisocabtagene-maraleucel","display_name":"lisocabtagene maraleucel","score":0.996999979019165},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9309999942779541},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9580000042915344},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8690000176429749},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor","display_name":"chimeric antigen receptor","score":0.7260000109672546},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8059999942779541},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.7149999737739563},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9369999766349792},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8799999952316284},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8019999861717224},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.6660000085830688},{"id":"https://openalex.org/keywords/secondary-cns-lymphoma","display_name":"secondary CNS lymphoma","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.8751661777496338},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.844353973865509},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6761836409568787},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6613940596580505},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.544170081615448},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.48210814595222473},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.47660961747169495},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.474230021238327},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.45064812898635864},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.42577987909317017},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.42467015981674194},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.401840478181839},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3511055111885071},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3244653046131134},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.27670255303382874},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.25034552812576294},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020522","descriptor_name":"Lymphoma, Mantle-Cell","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1200/jco.23.02214","doi":"https://doi.org/10.1200/jco.23.02214","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.23.02214","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:38072625","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38072625","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:11741176","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11741176","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11741176/pdf/nihms-2037856.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Clin Oncol","raw_type":"Text"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt5cx7w6d0","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/5cx7w6d0","pdf_url":"https://escholarship.org/content/qt5cx7w6d0/qt5cx7w6d0.pdf","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical Oncology, vol 42, iss 10","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:11741176","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11741176","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11741176/pdf/nihms-2037856.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Clin Oncol","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320333670","display_name":"Juno Therapeutics","ror":"https://ror.org/02dq5dx40"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389527245.pdf","grobid_xml":"https://content.openalex.org/works/W4389527245.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W2082708772","https://openalex.org/W2112023756","https://openalex.org/W2119147717","https://openalex.org/W2237195636","https://openalex.org/W2890354015","https://openalex.org/W2904633936","https://openalex.org/W2945874655","https://openalex.org/W3014583893","https://openalex.org/W3028144528","https://openalex.org/W3037002155","https://openalex.org/W3037370927","https://openalex.org/W3082855561","https://openalex.org/W3210008249","https://openalex.org/W4281901970","https://openalex.org/W4283827345","https://openalex.org/W4285098878","https://openalex.org/W4310106649","https://openalex.org/W4310113776","https://openalex.org/W4312094698","https://openalex.org/W4376636920","https://openalex.org/W4379513699","https://openalex.org/W4380078597","https://openalex.org/W4386282297"],"related_works":["https://openalex.org/W4407976286","https://openalex.org/W3095832065","https://openalex.org/W2954529696","https://openalex.org/W7204732048","https://openalex.org/W4400109288","https://openalex.org/W4386332213","https://openalex.org/W7162542774","https://openalex.org/W4380081053","https://openalex.org/W7204719248","https://openalex.org/W4379513699"],"abstract_inverted_index":{"PURPOSE":[0],"To":[1],"report":[2],"the":[3,8,15,168],"primary":[4],"analysis":[5],"results":[6],"from":[7],"mantle":[9],"cell":[10],"lymphoma":[11],"(MCL)":[12],"cohort":[13],"of":[14,37,64,115,118,129,132,199,242,284],"phase":[16],"I":[17],"seamless":[18],"design":[19],"TRANSCEND":[20],"NHL":[21],"001":[22],"(ClinicalTrials.gov":[23],"identifier:":[24],"NCT02631044":[25],")":[26],"study.":[27],"METHODS":[28],"Patients":[29],"with":[30,123,281,293,300],"relapsed/refractory":[31],"(R/R)":[32],"MCL":[33],"after":[34],"\u2265two":[35],"lines":[36,117,128],"previous":[38,116,127],"therapy,":[39,130],"including":[40,298],"a":[41,51,59],"Bruton":[42],"tyrosine":[43],"kinase":[44],"inhibitor":[45],"(BTKi),":[46],"an":[47],"alkylating":[48],"agent,":[49,53],"and":[50,90,138,153,185,209,231,266,277,289],"CD20-targeted":[52],"received":[54],"lisocabtagene":[55],"maraleucel":[56],"(liso-cel)":[57],"at":[58],"target":[60],"dose":[61],"level":[62],"(DL)":[63],"50":[65],"\u00d7":[66,72],"10":[67,73],"6":[68,74],"(DL1)":[69],"or":[70],"100":[71],"(DL2)":[75],"chimeric":[76],"antigen":[77],"receptor-positive":[78],"T":[79],"cells.":[80],"Primary":[81],"end":[82],"points":[83],"were":[84,134,226],"adverse":[85],"events":[86,251],"(AEs),":[87],"dose-limiting":[88],"toxicities,":[89],"objective":[91],"response":[92,187,200],"rate":[93,189,276],"(ORR)":[94],"by":[95],"independent":[96],"review":[97],"committee":[98],"per":[99],"Lugano":[100],"criteria.":[101],"RESULTS":[102],"Of":[103],"104":[104],"leukapheresed":[105],"patients,":[106],"liso-cel":[107],"was":[108,120,163,178,190,201,212,238],"infused":[109],"into":[110],"88.":[111],"Median":[112,159,197],"(range)":[113,160],"number":[114],"therapy":[119],"three":[121],"(1-11)":[122],"30%":[124],"receiving":[125],"\u2265five":[126],"73%":[131],"patients":[133,243,292],"age":[135],"65":[136],"years":[137],"older,":[139],"69%":[140],"had":[141,145,150,155],"refractory":[142,147],"disease,":[143,148],"53%":[144],"BTKi":[146],"23%":[149],"TP53":[151],"mutation,":[152],"8%":[154],"secondary":[156],"CNS":[157],"lymphoma.":[158],"on-study":[161],"follow-up":[162],"16.1":[164],"months":[165,203,214],"(0.4-60.5).":[166],"In":[167],"efficacy":[169],"set":[170],"(n":[171],"=":[172],"83;":[173],"DL1":[174],"+":[175],"DL2),":[176],"ORR":[177],"83.1%":[179],"(95%":[180,192,204,215],"CI,":[181,193,205,216],"73.3":[182],"to":[183,195,207,218],"90.5)":[184],"complete":[186],"(CR)":[188],"72.3%":[191],"61.4":[194],"81.6).":[196],"duration":[198],"15.7":[202],"6.2":[206],"24.0)":[208],"progression-free":[210],"survival":[211],"15.3":[213],"6.6":[217],"24.9).":[219],"Most":[220],"common":[221],"grade":[222,247,258,261,285],"\u22653":[223,262,286],"treatment-emergent":[224],"AEs":[225],"neutropenia":[227],"(56%),":[228],"anemia":[229],"(37.5%),":[230],"thrombocytopenia":[232],"(25%).":[233],"Cytokine":[234],"release":[235],"syndrome":[236],"(CRS)":[237],"reported":[239],"in":[240,253,264,269,291],"61%":[241],"(grade":[244,255],"3/4,":[245,256],"1%;":[246],"5,":[248,259],"0),":[249,260],"neurologic":[250],"(NEs)":[252],"31%":[254],"9%;":[257],"infections":[263,290],"15%,":[265],"prolonged":[267],"cytopenia":[268],"40%.":[270],"CONCLUSION":[271],"Liso-cel":[272],"demonstrated":[273],"high":[274],"CR":[275],"deep,":[278],"durable":[279],"responses":[280],"low":[282],"incidence":[283],"CRS,":[287],"NE,":[288],"heavily":[294],"pretreated":[295],"R/R":[296],"MCL,":[297],"those":[299],"high-risk,":[301],"aggressive":[302],"disease.":[303]},"counts_by_year":[{"year":2026,"cited_by_count":50},{"year":2025,"cited_by_count":45},{"year":2024,"cited_by_count":23},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-12-11T00:00:00"}